Patient Pathfinder: Clinical Trials
Clinical Trials for Chronic Lymphocytic Leukemia
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 179 active Chronic Lymphocytic Leukemia trials
Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
Study Type: Interventional Phase 2
Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
Study Type: Interventional Phase 2
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL
Study Type: Interventional Phase 2
A Study of Acalabrutinib vs Investigator’s Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
Study Type: Interventional Phase 3
A Study Of The Selective PKC-β Inhibitor MS- 553
Study Type: Interventional Phase 1
Safe Accelerated Venetoclax Escalation in CLL
Study Type: Interventional Phase 1
A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
Study Type: Interventional Phase 2
There are 179 active Chronic Lymphocytic Leukemia trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now